Kowa Pharmaceuticals America

• NCT02344290

  Collaborator, Phase 3, Completed, 7,769 people, 22 Jan 2015

• NCT01695954

  Collaborator, Phase 1, Completed, 34 people, 28 Sept 2012

• NCT01660191

  Collaborator, Phase 4, Completed, 134 people, 8 Aug 2012

• NCT01301066

  Collaborator, Phase 4, Completed, 252 people, 23 Feb 2011

• Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

  20 Aug 2026

Sources: api.crossref.org

• Hypertension Prevalence and Control at Trial Entry in the REPRIEVE Study Population: Results From a Secondary Analysis

  Grants or research support, 20 Aug 2026

• Thymic health consequences in adults

  Grants or research support, 18 Mar 2026

Sources: pubmed.ncbi.nlm.nih.gov